GlassScriptPhysician profile
Jorge A Dabdoub
NPI 1699729376
$4,189.70
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,381 · 2020: $881 · 2021: $1,423 · 2022: $504.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $708.40 | 2019-2022 | |
| Glaxosmithkline, LLC. | $471.50 | 2019-2022 | |
| Allergan, INC. | $436.00 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.47 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $207.17 | 2019-2021 | |
| Pfizer INC. | $205.76 | 2019-2021 | |
| Astellas Pharma US INC | $199.10 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $188.08 | 2019-2022 | |
| Novo Nordisk INC | $182.93 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $158.98 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $93.24 | 2019-2021 | |
| Amarin Pharma, INC. | $91.72 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $90.08 | 2021-2022 | |
| Amgen INC. | $58.23 | 2019-2021 | |
| Eisai INC. | $56.72 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $54.47 | 2019-2021 | |
| Lilly USA, LLC | $50.36 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.06 | 2022 | |
| Endo Pharmaceuticals INC. | $46.38 | 2021 | |
| Dermira, INC. | $46.29 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.33 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $43.21 | 2019-2020 | |
| Abbott Laboratories | $39.56 | 2021 | |
| Novartis Pharmaceuticals Corporation | $36.87 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $34.67 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $30.43 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $26.69 | 2021 | |
| Jazz Pharmaceuticals INC. | $24.44 | 2021 | |
| Becton, Dickinson and Company | $21.57 | 2020 | |
| Daiichi Sankyo INC. | $18.60 | 2021 | |
| Shire North American Group INC | $17.69 | 2019 | |
| Almatica Pharma LLC | $17.45 | 2021 | |
| Scilex Pharmaceuticals INC. | $16.58 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.98 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.49 | 2022 | |
| Biodelivery Sciences International, INC. | $12.91 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Dabdoub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.